Characteristics | No diabetes (n = 1421) | T2DM (n = 1421) | Standardised difference (%) | P value |
---|---|---|---|---|
Age, median (IQR) | 67.6 (58.8, 75.5) | 67.0 (59.1, 73.7) | 1.9 | 0.22 |
Gender (Male) | 921 (64.8%) | 875 (61.6%) | 6.7 | 0.07 |
Country of birth | ||||
Non-Australian | 435 (30.6%) | 432 (30.4%) | 0.5 | 0.80 |
Australian | 933 (65.7%) | 929 (65.4%) | 0.6 | Â |
Unknown | 53 (3.7%) | 60 (4.2%) | 2.5 | Â |
Language spoken | ||||
English | 1253 (88.2%) | 1253 (88.2%) | 0.0 | 0.93 |
Not English | 121 (8.5%) | 124 (8.7%) | 0.8 | Â |
Unknown | 47 (3.3%) | 44 (3.1%) | 1.2 | Â |
SEIFA Index, median (IQR) | 6.0 (4.0, 7.0) | 6.0 (4.0, 7.0) | 0.7 | 0.57 |
Stage of CKD | ||||
No known CKD | 1343 (94.5%) | 1333 (93.8%) | 3.0 | 0.96 |
CKD stage 2 | 6 (0.4%) | 5 (0.4%) | 1.1 | Â |
CKD stage 3 | 41 (2.9%) | 45 (3.2%) | 1.6 | Â |
CKD stage 4 | 15 (1.1%) | 18 (1.3%) | 2.0 | Â |
CKD stage 5 | 12 (0.8%) | 15 (1.1%) | 2.2 | Â |
CKD stage unknown | 4 (0.3%) | 5 (0.4%) | 1.3 | Â |
Indication for angiogram | ||||
Chest pain | 317 (22.3%) | 315 (22.2%) | 0.2 | 1.00 |
History of acute coronary event | 120 (8.4%) | 121 (8.5%) | Â | Â |
Breathlessness | 115 (8.1%) | 119 (8.4%) | Â | Â |
Positive non-invasive test | 504 (35.5%) | 506 (35.6%) | Â | Â |
Other | 365 (25.7%) | 360 (25.3%) | Â | Â |
Year of angiogram | ||||
2013 | 141 (9.9%) | 147 (10.3%) | 2.0 | 0.95 |
2014 | 210 (14.8%) | 207 (14.6%) | Â | Â |
2015 | 208 (14.6%) | 206 (14.5%) | Â | Â |
2016 | 209 (14.7%) | 220 (15.5%) | Â | Â |
2017 | 229 (16.1%) | 242 (17.0%) | Â | Â |
2018 | 226 (15.9%) | 209 (14.7%) | Â | Â |
2019 | 198 (13.9%) | 190 (13.4%) | Â | Â |
Valvular disease | 140 (9.9%) | 145 (10.2%) | 1.2 | 0.75 |
Peripheral vascular disorders | 30 (2.1%) | 34 (2.4%) | 1.9 | 0.61 |
Congestive heart failure | 133 (9.4%) | 135 (9.5%) | 0.5 | 0.90 |
Cardiac arrhythmia | 103 (7.2%) | 107 (7.5%) | 1.1 | 0.77 |
Hypertension | 201 (14.1%) | 190 (13.4%) | 2.2 | 0.55 |